BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) Institutional Ownership and Insiders Activity
BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) is widely held by institutional investors, with 66 firms reporting positions valued at approximately $452.02M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Cormorant Asset Management, Lp is the largest disclosed holder, reporting approximately $136.23M in BBOT holdings in its latest filing.
Recent insider activity includes 5 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
66
Total Reported Value
$452.02M
Largest Holder
Cormorant Asset Management, Lp
Largest Position
$136.23M
Insider Transactions (90d)
5
Latest Filing Quarter
Q2 2026
New Institutional Positions
50
Funds Exiting Positions
0
Top Institutional Owners
View allInvestorReported Balance
- Cormorant Asset Management, Lp$136.23M
- Deerfield Management Company, L.P.$37.23M
- Omega Fund Management, Llc$25.07M
- Alphabet Inc.$21.51M
- Ecor1 Capital, Llc$21.51M
Related BBOT Institutional Insights:
- BBOT 13F Institutional Holders
- BBOT Superinvestors
- BBOT Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- BBOT Insider Trading & SEC Form 4 Activity
- BBOT Articles
- Top Institutional Investor Stock Rankings